Selecting Biomarker Methods for Evolving Oncology Research Workflows
Fill out the form below, and we shall send your colleague an invitation to the "Selecting Biomarker Methods for Evolving Oncology Research Workflows" event.
As biomarker testing becomes central to precision oncology workflows, research laboratories are under increasing pressure to select and integrate methods that deliver reliable results across diverse sample types, including liquid biopsy.
This webinar explores how to make informed methodological decisions when implementing and combining approaches for biomarker detection.
Through real-world examples, attendees will gain insight into balancing sensitivity, turnaround time, and sample constraints, alongside key considerations for verification and workflow design. Join to better align your research laboratory strategy with evolving clinical and translational demands.
- Gain an overview of NGS, qPCR and dPCR targeted for biomarker detection across FFPE, cytology, and liquid biopsy samples
- Learn to integrate multiple methodologies for optimal results, including key considerations like limitations, workflows, and turnaround time
- Discover best practices for analytical validation to help ensure reliable implementation in research laboratories
